Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07663136 · ClinicalTrials.gov registry record · NA
Finding Immune Nascent Type 1 Diabetes
A NA study, sponsored by Indiana University.
- Not yet
- Registry status
- NA
- Development phase
- 3,800
- Enrollment target
NCT07663136 is a NA study that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 3,800 participants.
The verdict
NCT07663136, a NA study, has not yet begun recruiting, sponsored by Indiana University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 3,800 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.
Interventions
- BEHAVIORAL phone call
- BEHAVIORAL email/mail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,800 participants |
| Start Date | 2026-06 |
| Est. Completion | 2029-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07663136
The ClinicalTrials.gov registry entry for NCT07663136 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 3,800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which phone call is the first listed.
NCT07663136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07663136 about?
NCT07663136 is a clinical study titled "Finding Immune Nascent Type 1 Diabetes". The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment commu...
What is the current status of trial NCT07663136?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 3,800 participants. The study started on 2026-06. Estimated completion is 2029-06.
What interventions are being tested in trial NCT07663136?
The interventions under investigation include: phone call (BEHAVIORAL), email/mail (BEHAVIORAL).
Who is sponsoring clinical trial NCT07663136?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.